대구 , 경북 지역 혈액투석 환자에서 C 형 간염의 유병율 = Prevalence of Anti - HCV in Hemodialysis Patients in taegu and Kyeongbuk , Korea

다국어 초록 (Multilingual Abstract)

To determine the prevalence and risk factor of anti-HCV in ESBD patients under chronic maitenance hemodialysis, the prevalence of serum antibodies to hepatitis C Virus (Anti-HCV) was assessed by an enzyme immunoassay (Abbott HCV EIA) in 253 patients with long-term Hemodialysis in Daegu & Kyoungbuk. 15 patients (5.9%) were anti-HCV positive. All dialysis patients had the history of transfusion. The number of transfusion units was not significant in anti-HCV positive patients (mean 17±20 pints) in comparison with the number in anti-HCV negative patients (mean 16±17 pints). The frequency of hemodialysis was also not significant in anti-HCV positive patients (mean 477±618 ) compared with anti-HCV negative patients (mean 462±616). The mean duration of hemodialysis was significantly higher (p<0.001) in the anti-HCV positive patients (74±42 months) in comparison with anti-HCV negative patients (45±41 months). We concluded that the prevalence of anti-HCV in hemodialysis patients is 5.9% and that HCV infection is significantly mlated with the duration of hemodialysis rather than the number of transfusion units and the frequency of hemodialysis